Evidence map›Paper›PMID 39326867›Full record

ArticleACS applied bio materials2024

Water-Soluble Rotaxane-Type Porphyrin Dyes as a Highly Membrane-Permeable and Durable Photosensitizer Suitable for Photodynamic Therapy.

Yuki Ohishi, Taiki Ichikawa, Satoru Yokoyama, Juri Yamashita, Munetaka Iwamura, Koichi Nozaki, Yue Zhou, Junya Chiba, Masahiko Inouye

Abstract read
In one paragraph

Article in ACS applied bio materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuki OhishiGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0001-9684-5603
Taiki IchikawaGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Satoru YokoyamaGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Juri YamashitaGraduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Munetaka IwamuraGraduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.ORCID 0000-0002-4888-9086
Koichi NozakiGraduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
Yue ZhouGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Junya ChibaGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0003-2368-7995
Masahiko InouyeGraduate School of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.ORCID 0000-0002-2861-5870

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyrins have emerged as highly effective photosensitizers in the field of photodynamic therapy (PDT) because of their high singlet oxygen generation efficiency. However, most porphyrin derivatives do not have adequate water solubility and cell membrane permeability suitable for use in PDT. In addition, they frequently suffer from low durability under photoirradiation. Here, we propose rotaxane-type photosensitizers, in which a porphyrin axle is irreversibly encapsulated within cyclodextrins (CDs), to overcome the drawbacks of porphyrins for PDT. The rotaxane-type photosensitizers were synthesized in high yields by employing a cooperative capture strategy. The CD derivatives worked as a transparent shell to impart a porphyrin axle not only with water solubility but also with photostability. These rotaxanes showed higher cell membrane permeability and photoinduced cytotoxic abilities than talaporfin sodium, presently used as a clinical photosensitizer. The rotaxane-based photosensitizer could have potential for being ideal PDT drugs.

Indexed as

Biocompatible MaterialsMaterials TestingPhotochemotherapyPhotosensitizing AgentsPorphyrinsRotaxanesSolubilityWaterAntineoplastic AgentsCell Membrane PermeabilityCell SurvivalColoring AgentsDrug Screening Assays, AntitumorHumansMolecular StructureParticle SizeAntineoplastic AgentsBiocompatible MaterialsColoring AgentsPhotosensitizing AgentsPorphyrinsRotaxanesWatercyclodextrinphotodynamic therapyphotosensitizerporphyrinrotaxane

Identifiers

PMID39326867
PMCPMC11497202

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.